LTRN Lantern Pharma Inc.: institutional ownership and insider trading

41 funds reported holding $13.1M of Lantern Pharma Inc. in their latest 13F filings; in Q2 2026 funds net bought $3.28M, with 12 new positions and 6 funds selling out; over the last 12 months insiders bought $200K and sold $0 on the open market.

LTRN revenue and earnings

Famous investors holding LTRN

Largest institutional holders of LTRN

  1. Empery Asset Management, LP — $3.51M
  2. CM Management, LLC — $2.09M
  3. VANGUARD CAPITAL MANAGEMENT LLC — $1.77M
  4. RENAISSANCE TECHNOLOGIES LLC — $1.21M
  5. VANGUARD GROUP INC — $1.16M
  6. BIOS Capital Management, LP — $1.04M
  7. GEODE CAPITAL MANAGEMENT, LLC — $429K
  8. VANGUARD FIDUCIARY TRUST CO — $208K
  9. CITADEL ADVISORS LLC — $200K
  10. Westside Investment Management, Inc. — $200K

Recent LTRN insider trades

5%+ owners

Who owns the most LTRN stock?

The largest institutional holders of Lantern Pharma Inc. in the latest 13F filings are Empery Asset Management, LP ($3.51M), CM Management, LLC ($2.09M), VANGUARD CAPITAL MANAGEMENT LLC ($1.77M).

Are insiders buying or selling LTRN?

Over the last 12 months insiders bought $200K and sold $0 of Lantern Pharma Inc. stock on the open market (SEC Form 4).

Which famous investors own LTRN?

Renaissance Technologies, Ken Griffin.

Which ETFs hold LTRN?

1 ETFs and mutual funds hold it among their top 100 positions, including MEDX.

All LTRN 13F holders · All LTRN insider trades